FDA Approves Pembrolizumab Immunotherapy for Advanced Liver Cancer November 9, 2018October 31, 2024 Arthur N. Brodsky, PhD
Cemiplimab Becomes First Treatment Approved for CSCC September 29, 2018October 31, 2024 Arthur N. Brodsky, PhD
First Immunotherapy Approved for Patients with Small Cell Lung Cancer August 20, 2018October 31, 2024 Arthur N. Brodsky, PhD
First Checkpoint Immunotherapy Approved for Advanced Cervical Cancer June 13, 2018December 14, 2022 Arthur N. Brodsky, PhD
Kymriah, a CAR T cell immunotherapy, approved for lymphoma May 3, 2018December 14, 2022 Arthur N. Brodsky, PhD